

 
 
Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
 
Most Trending
NVCR
NovoCure Limited Ord
$12.82
 Login to see NovoCure Limited Ord (NVCR)  Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
  Login to see NovoCure Limited Ord (NVCR)  Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Strengths

Upgraded on attractively valued
Risk Analysis

Earnings are forecast to decrease
Chart
$14.05 (-8.75%)
$11.39 (+12.55%)
$16.92 (-24.23%)
$17.82 (-28.06%)
NVCR has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

 
NVCR overall standing based on key factors, offering insights into analysts perspectives and market expectations.
 Hover over the category for more information
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to decrease

NVCR Analysts opinion is negative but has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
 
 
NVCR Street view is extremely bullish and have negative views on the near-term outlook
Average key support and resistance price levels.
 Login to display
  Login to displayNVCR Earnings
The TTM reflects 12-month period, providing review of NVCR financial performance.
The company financial health has moderately improved over the past year
Financial Score
What is NVCR current stock price?
What are NVCR stock strengths?
What risks are associated with NVCR stock?
When is NVCR next earnings report?
What is NVCR market cap and volume?
What is NVCR's current Stock IQ?
Should I buy NVCR stock right now?
Is NVCR a Strong Buy right now?
What does a 'Strong Buy' rating mean for NVCR?
What does a 'Strong Sell' rating mean for NVCR?
What factors influence NVCR's Stock IQ?
 
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
NVCR
NovoCure Limited Ord
Current Price
$12.82
Stock Insights
Strengths

Upgraded on attractively valued
Risk Analysis

Earnings are forecast to decrease
 Login to unlock NovoCure Limited Ord (NVCR) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
  Login to unlock NovoCure Limited Ord (NVCR) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid  
Chart
$14.05 (-8.75%)
$11.39 (+12.55%)
$16.92 (-24.23%)
$17.82 (-28.06%)
NVCR Analysts Opinion
 
NVCR Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
 Hover over the category for more information
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to decrease

NVCR Analysts opinion is negative but has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
 
 
NVCR Street view is extremely bullish and have negative views on the near-term outlook
NVCR has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Average key support and resistance price levels.
 Login to display
  Login to displayNVCR Earnings
The TTM data reflects the most recent 12-month period, providing overview of NVCR financial performance.
NVCR Financial Health
The company financial health has moderately improved over the past year
Financial Score
NVCR Latest Analysis
Novocure Posts Wider Loss In Q3 . (RTTNews) - Novocure (NVCR) reported a third quarter net loss of $37.3 million compared to a loss of $30.6 million prior year. Net loss per ordinary share was $0.33 compared to a loss of $0.28. Analysts on average expected the company to report a loss per share of $0.42 for the
Today
NovoCure GAAP EPS of -$0.33 beats by $0.09 revenue of $167M beats by $8.06M.
Today
NovoCure: Buy Rating As Pipeline Gains Drive Renewed Momentum.
Fri Oct 17, 2025
 
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
NVCR Stock trends
NVCR Stock performance
NVCR Stock analysis
NVCR investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS"). 
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.